These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 22607149)

  • 1. The redox biology of schistosome parasites and applications for drug development.
    Huang HH; Rigouin C; Williams DL
    Curr Pharm Des; 2012; 18(24):3595-611. PubMed ID: 22607149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting schistosome histone modifying enzymes for drug development.
    Pierce RJ; Dubois-Abdesselem F; Lancelot J; Andrade L; Oliveira G
    Curr Pharm Des; 2012; 18(24):3567-78. PubMed ID: 22607147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
    Vale N; Gouveia MJ; Rinaldi G; Brindley PJ; Gärtner F; Correia da Costa JM
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28264841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physico-biochemical study on potential redox-cyclers as antimalarial and anti-schistosomal drugs.
    Johann L; Lanfranchi DA; Davioud-Charvet E; Elhabiri M
    Curr Pharm Des; 2012; 18(24):3539-66. PubMed ID: 22607146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insight into praziquantel against various developmental stages of schistosomes.
    Wu W; Wang W; Huang YX
    Parasitol Res; 2011 Dec; 109(6):1501-7. PubMed ID: 21984370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomiasis--a century searching for chemotherapeutic drugs.
    Ribeiro-dos-Santos G; Verjovski-Almeida S; Leite LC
    Parasitol Res; 2006 Oct; 99(5):505-21. PubMed ID: 16636847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
    Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
    Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schistosomiasis control: keep taking the tablets.
    Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
    Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinases as potential targets for novel anti-schistosomal strategies.
    Beckmann S; Leutner S; Gouignard N; Dissous C; Grevelding CG
    Curr Pharm Des; 2012; 18(24):3579-94. PubMed ID: 22607148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.
    El Kouni MH
    Comp Biochem Physiol B Biochem Mol Biol; 2017 Nov; 213():55-80. PubMed ID: 28735972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-positioning protein-kinase inhibitors against schistosomiasis.
    Gelmedin V; Dissous C; Grevelding CG
    Future Med Chem; 2015; 7(6):737-52. PubMed ID: 25996067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study progress on the mode of action of praziquantel against schistosomes].
    Xiao SH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Dec; 25(6):492-502. PubMed ID: 18441900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schistosomiasis and pregnancy.
    Friedman JF; Mital P; Kanzaria HK; Olds GR; Kurtis JD
    Trends Parasitol; 2007 Apr; 23(4):159-64. PubMed ID: 17336160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the role of schistosome mating structure in the maintenance of drug-resistant strains.
    Xu D; Curtis J; Feng Z; Minchella DJ
    Bull Math Biol; 2006 Feb; 68(2):209-29. PubMed ID: 16794928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?
    Dissous C; Grevelding CG
    Trends Parasitol; 2011 Feb; 27(2):59-66. PubMed ID: 20920890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis.
    Lyu H; Petukhov PA; Banta PR; Jadhav A; Lea WA; Cheng Q; Arnér ESJ; Simeonov A; Thatcher GRJ; Angelucci F; Williams DL
    ACS Infect Dis; 2020 Mar; 6(3):393-405. PubMed ID: 31939288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will new antischistosomal drugs finally emerge?
    Cioli D; Valle C; Angelucci F; Miele AE
    Trends Parasitol; 2008 Sep; 24(9):379-82. PubMed ID: 18675590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
    Liu LX; Li-Li J; Qiong C; Xiao-Lin F
    Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosomiasis chemotherapy.
    Thétiot-Laurent SA; Boissier J; Robert A; Meunier B
    Angew Chem Int Ed Engl; 2013 Jul; 52(31):7936-56. PubMed ID: 23813602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.